Arrivent Biopharma Inc. (AVBP)
Market Closed
3 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
31. 03
+0.52
+1.7044%
$
1.4B Market Cap
- P/E Ratio
- Div Yield
465,400 Volume
- Eps
$ 30.51
Previous Close 
Want to track AVBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arrivent Biopharma Inc. (AVBP) Statistics
Valuation metrics
Market Cap 1.4B
Enterprise value 1.25B
Trailing P/E (ttm) -8.2
Forward P/E -
PEG ratio -2.28
Price/Sales (ttm) -
Price/Book (mrq) 3.92
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 427.52K
Average volume (90 days) 596.78K
Price summary
52-Week low 17
52-Week high 35.83
Beta -
50-Day moving average 30.7
200-Day moving average 26.82
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.5%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.16%
Book value per share (mrq) 7.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
